TrialClinical and experimental nephrology2021

Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan.

Satoru Muto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.